Investor Type | Firm |
Type of Fund | Private Equity Fund |
Industries | PropTech • AgroTech • FinTech (& Financials services) • Retail (& E-Commerce) • HealthTech (& Fitness) • Web Security (& Privacy) • Logistics (& Distribution) • Medical Devices (& Hospital Services) • Real Estate (& Construction) • Healthcare (& Wellness) |
Stages | Seed, Series B |
Investing | United States • Australia • South Africa • Singapore • Hong Kong • Israel • Taiwan • Austria • Europe • Poland • Asia • Romania |
Investment Range | $100,000 - $5,000,000 |
Investment Sweet Spot | $1,500,000 |
BlueRed Partners is a private equity fund based in Madrid, Spain, with focuses across diverse industries including PropTech, AgroTech, FinTech and Financial Services, Retail and E-Commerce, HealthTech and Fitness, Web Security and Privacy, Logistics and Distribution, Medical Devices and Hospital Services, Real Estate and Construction, and Healthcare and Wellness. Specializing in equity investments, BlueRed Partners targets funding opportunities between €100,000 and €5,000,000, with a sweet spot at €1,500,000 for their investments. Their specialities include providing seed funding and Series B round investments. BlueRed Partners prides itself on offering flexible financing solutions oriented towards the Southern Europe lower-mid market. Oquendo Capital is affiliated with BlueRed Partners and details its experience on its website in providing preferred equity and debt instruments for family-owned businesses and financial investors in Spain, France, Italy, and Portugal. Oquendo Capital, founded in 2007, is independent and dominant in private debt management in the European market, with over €1.2 billion invested in more than 100 companies. The fund's capital comes from a diversified group of institutional investors, including pension funds, insurance companies, nonprofits, and both public and private investors. Oquendo Capital is known for its experience, flexibility in tailoring financial instruments to each company's unique needs, independence from conflicts of interest, and reliable and transparent investment decision-making process.